New drug trial aims to tame debilitating nerve pain
Disease control
Not yet recruiting
This study is testing whether an intravenous drug called AMBTX-01 can reduce pain and other symptoms in adults with a specific type of Complex Regional Pain Syndrome (CRPS-1). About 270 participants will receive either the drug or a placebo over four infusions, and researchers wi…
Phase: PHASE3 • Sponsor: Ambros Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC